...
首页> 外文期刊>Expert Review of Molecular Diagnostics >Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetes.
【24h】

Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetes.

机译:通过实时逆转录酶PCR定量趋化因子:在1型糖尿病中的应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Type 1 diabetes is a T-cell mediated autoimmune disease, characterized by the destruction of insulin-producing pancreatic beta-cells. This review will discuss the role of chemokines in the recruitment of immune cells leading to the pathology of this disease. There will be a focus on the quantification of chemokines and chemokine receptors by the recently developed real-time reverse transcriptase PCR technique. Today, this technique is in widespread use for analysis of chemokines in cells, tissues and tissue biopsies. The minute amount of tissue needed for analysis, as well as the very high sensitivity of this method, make it the method of choice for analysis of chemokines, which are often expressed at very low levels in target tissues. However, validation and optimization of the technique is of crucial importance for obtaining reliable results.
机译:1型糖尿病是T细胞介导的自身免疫性疾病,其特征是破坏了产生胰岛素的胰岛β细胞。这篇综述将讨论趋化因子在招募导致这种疾病病理的免疫细胞中的作用。通过最近开发的实时逆转录酶PCR技术将重点研究趋化因子和趋化因子受体的定量。如今,该技术已广泛用于分析细胞,组织和组织活检组织中的趋化因子。分析所需的微量组织以及该方法的极高灵敏度使其成为分析趋化因子的首选方法,趋化因子通常在靶组织中的表达水平非常低。但是,该技术的验证和优化对于获得可靠的结果至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号